Non-adherence to statin therapy: a major challenge for preventive cardiology.
about
Medication adherence in the general populationClinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trialIs the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects.Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review.Behavior change, health, and health disparities: an introductionThe polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population.Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients.Relation between Body Humors and Hypercholesterolemia: An Iranian Traditional Medicine Perspective Based on the Teaching of Avicenna.Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity.Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Adherence to lipid-lowering treatment: the patient perspective.Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veteransPrevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapyAntidepressants in primary care: patients' experiences, perceptions, self-efficacy beliefs, and nonadherence.Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies.Pharmacotherapy of dyslipidemias in the adult population.Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review.Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?Novel strategies for managing dyslipidemia: treatment beyond statins.Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?Statins and Nonadherence: Should We RELATE Better?Adherence to statin therapy in patients with type 2 diabetes: An important dilemma.Adherence to lipid-lowering agents among 11,042 patients in clinical practice.Adherence to preventive statin therapy according to socioeconomic position.No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study.Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis.Seeing what's happening on the inside: patients' views of the value of diagnostic cardiac computed tomography angiography.Predicting non-adherence in patients with familial hypercholesterolemia.Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease - A population-wide electronic cohort study.Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors.Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia
P2860
Q28484426-42F0D788-6015-4DFF-9DDF-7CB6A4122E18Q31161044-E6C00C8D-846F-4146-A30D-AE667C223CF9Q34075903-1A88B885-CB8E-45C1-B6FC-3CEBF2CE33DBQ34366183-6FB08A04-DDF0-425C-8CC8-269D564BB8A3Q34491726-F0CA5E1A-C305-47F0-8277-5AA837AD30FAQ34671958-E60E012C-E2C9-462B-A175-DF048E416AEBQ34953788-31DEE606-1B48-49A7-A5D6-FFBB82FFC9AFQ35112482-750F607C-21D9-4F68-AF61-D30B63C55D70Q35753875-392E0A1E-7324-4E4C-B9BF-0D7244A70AE4Q35903382-0E7BD9CF-0D11-4D58-A8AF-A797CAAA7C24Q36022638-044B13C4-C1CD-4F31-8588-622184995290Q36064234-A98775B1-C3AB-4503-938B-C5C7FD3545DCQ36076131-4FD34643-FC21-401B-9C49-DF0AAD5AFEA0Q36394334-159BC6CE-04FE-43C2-A177-BBBF5249C770Q36503503-6A323A80-171C-4C90-8729-99BA493149BBQ36962326-14864F69-68DD-4D4E-8086-A6ECCD0D718FQ37027567-077BEF9F-7A31-41C6-92AC-D08FB730D97BQ37588434-157317D7-297C-4F7A-BD79-0418C7353741Q37772510-4AD0D460-7DAC-40C8-BD51-A12EE94F93FBQ37801374-8E4540CD-FE1A-433D-BFD0-5EE5F4CC8866Q37826757-68C9B345-2C5E-4DFC-B35D-784EF7930373Q37923968-13B72DFE-17E7-4726-96CA-5D95D049B2DBQ38012612-D4E11707-7F21-4331-A081-DFE4F9768D6DQ38074335-06175F24-B66E-4BE5-BE83-2C7CAAF67974Q38228757-4B0642D2-BA90-467C-BC33-86ECE80888F2Q38398011-662EE5F5-AF19-4D6F-91FD-7F4E57A6C4A1Q39725731-747D7436-1442-4E64-BFBE-E6213530C430Q39738970-3610EB3B-2175-4BC2-B1BE-1A0B7664160CQ44003644-023182EA-B43A-4C21-8FDA-8FA80D850C5BQ45842777-B1E781A6-B0F3-466A-B89F-9C8C15B00370Q47802987-8F660F81-FC5D-4E0B-A3DF-6CC64D5F031FQ47829040-960CFF27-DE65-4AC8-BAA8-EFA33F075623Q49099766-C7ABBEA4-64AF-4698-AD10-156E8B538B11Q52361513-510D1CE4-B9E6-4FA0-8727-63BCE91A5F10Q52562837-E244EF6E-0C4B-45C9-BDE8-489136F4876DQ52804432-DAE09581-8E5C-4D47-A2F1-6AD14556DA43Q59126098-800242F1-7558-466B-AD7C-144AF7107B94
P2860
Non-adherence to statin therapy: a major challenge for preventive cardiology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@en
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@nl
type
label
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@en
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@nl
prefLabel
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@en
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@nl
P2093
P2860
P1476
Non-adherence to statin therapy: a major challenge for preventive cardiology.
@en
P2093
V M Connaughton
P2860
P304
P356
10.1517/14656560903376186
P407
P577
2009-12-01T00:00:00Z